LEADER 01840oam  2200517   450 
001 9910714941903321
005 20200921111106.0
035   $a(CKB)3460000000108731
035   $a(OCoLC)809130198
035   $a(OCoLC)993460000000108731
035   $a(EXLCZ)993460000000108731
100   $a20120904d2010      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aExploring the relationship between medication and veteran suicide $ehearing before the Committee on Veterans' Affairs, U.S. House of Representatives, One Hundred Eleventh Congress, second session, February 24, 2010
210  1$aWashington :$cUnited States Government Printing Office,$d2010.
215   $a1 online resource (iii, 97 pages)
300   $a"Serial no. 111-62."
320   $aIncludes bibliographical references.
517   $aExploring the relationship between medication and veteran suicide 
606   $aPsychotropic drugs$xSide effects
606   $aAntidepressants$xSide effects
606   $aVeterans$xSuicidal behavior$zUnited States
606   $aVeterans$xMental health$xTreatment$zUnited States
606   $aSuicide$xRisk factors
608   $aLegislative hearings.$2lcgft
615  0$aPsychotropic drugs$xSide effects.
615  0$aAntidepressants$xSide effects.
615  0$aVeterans$xSuicidal behavior
615  0$aVeterans$xMental health$xTreatment
615  0$aSuicide$xRisk factors.
801  0$bOCLCE
801  1$bOCLCE
801  2$bOCLCQ
801  2$bOCLCA
801  2$bOCLCF
801  2$bOCLCO
801  2$bOCLCA
801  2$bGPO
906   $aBOOK
912   $a9910714941903321
996   $aExploring the relationship between medication and veteran suicide$93529846
997   $aUNINA